SMRI Contributions to Drug Development for Schizophrenia and Bipolar Disorder

ISSN： 0586-7614

Source： Schizophrenia Bulletin, Vol.39, Iss.3, 2013-05, pp. : 481-482

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Bipolar Disorder and Schizophrenia: Convergent Molecular Data

By Berrettini Wade

NeuroMolecular Medicine, Vol. 5, Iss. 1, 2004-02 ,pp. : 109-118

Humana Press, Inc

Access to resources Recommend Favorite

A search for genes involved in bipolar affective disorder and schizophrenia

By Nygaard Mette

Nordic Journal of Psychiatry, Vol. 58, Iss. 1, 2004-01 ,pp. : 72-72

Informa Healthcare

Access to resources Recommend Favorite

Inhaled loxapine for acute agitation in schizophrenia and bipolar disorder

By Nordstrom Kimberly

Future Neurology, Vol. 4, Iss. 5, 2009-09 ,pp. : 539-545

Future Medicine

Access to resources Recommend Favorite

Toward Convergence in the Medication Treatment of Bipolar Disorder and Schizophrenia

By Citrome Leslie Goldberg Joseph Stahl Stephen

Harvard Review of Psychiatry, Vol. 13, Iss. 1, 2005-01 ,pp. : 28-42

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Schizophrenia and Bipolar Disorder are Distinguished Mainly by Differences in Neurodevelopment

By Walker Jenny Curtis Vivienne Shaw Philip Murray Robin M.

Neurotoxicity Research, Vol. 4, Iss. 5, 2002-01 ,pp. : 427-436

Springer Publishing Company

Access to resources Recommend Favorite